TACTILE SYSTEMS TECHNOLOGY I (TCMD) Stock Fundamental Analysis
USA - NASDAQ:TCMD - US87357P1003 - Common Stock
24.86 USD
+0.99 (+4.15%)
25 USD
+0.14 (+0.56%)
We assign a fundamental rating of 6 out of 10 to TCMD. TCMD was compared to 189 industry peers in the Health Care Equipment & Supplies industry. TCMD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TCMD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
TCMD had positive earnings in the past year.
TCMD had a positive operating cash flow in the past year.
In multiple years TCMD reported negative net income over the last 5 years.
TCMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
TCMD has a better Return On Assets (5.54%) than 83.07% of its industry peers.
TCMD has a Return On Equity of 7.75%. This is amongst the best in the industry. TCMD outperforms 80.95% of its industry peers.
With a decent Return On Invested Capital value of 5.85%, TCMD is doing good in the industry, outperforming 79.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.54% | ||
| ROE | 7.75% | ||
| ROIC | 5.85% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TCMD has a better Profit Margin (5.06%) than 76.72% of its industry peers.
TCMD's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 6.30%, TCMD is doing good in the industry, outperforming 71.96% of the companies in the same industry.
In the last couple of years the Operating Margin of TCMD has grown nicely.
With a Gross Margin value of 49.70%, TCMD perfoms like the industry average, outperforming 43.92% of the companies in the same industry.
In the last couple of years the Gross Margin of TCMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.3% | ||
| PM (TTM) | 5.06% | ||
| GM | 49.7% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
TCMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TCMD has more shares outstanding than it did 1 year ago.
TCMD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TCMD has been reduced compared to a year ago.
2.2 Solvency
TCMD has an Altman-Z score of 6.09. This indicates that TCMD is financially healthy and has little risk of bankruptcy at the moment.
TCMD's Altman-Z score of 6.09 is amongst the best of the industry. TCMD outperforms 83.07% of its industry peers.
The Debt to FCF ratio of TCMD is 0.63, which is an excellent value as it means it would take TCMD, only 0.63 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of TCMD (0.63) is better than 92.06% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that TCMD is not too dependend on debt financing.
TCMD has a Debt to Equity ratio of 0.11. This is in the better half of the industry: TCMD outperforms 64.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 6.09 |
ROIC/WACC0.68
WACC8.6%
2.3 Liquidity
TCMD has a Current Ratio of 3.79. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
TCMD has a Current ratio of 3.79. This is in the better half of the industry: TCMD outperforms 67.20% of its industry peers.
A Quick Ratio of 3.36 indicates that TCMD has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.36, TCMD is doing good in the industry, outperforming 69.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.36 |
3. Growth
3.1 Past
TCMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
The Earnings Per Share has been growing slightly by 4.86% on average over the past years.
TCMD shows a small growth in Revenue. In the last year, the Revenue has grown by 6.76%.
The Revenue has been growing by 9.11% on average over the past years. This is quite good.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.33%
3.2 Future
Based on estimates for the next years, TCMD will show a very strong growth in Earnings Per Share. The EPS will grow by 30.86% on average per year.
Based on estimates for the next years, TCMD will show a quite strong growth in Revenue. The Revenue will grow by 8.78% on average per year.
EPS Next Y-11.22%
EPS Next 2Y12.18%
EPS Next 3Y30.86%
EPS Next 5YN/A
Revenue Next Year6.59%
Revenue Next 2Y7.62%
Revenue Next 3Y8.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 32.29 indicates a quite expensive valuation of TCMD.
TCMD's Price/Earnings ratio is a bit cheaper when compared to the industry. TCMD is cheaper than 73.02% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.83. TCMD is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 27.82, which means the current valuation is very expensive for TCMD.
TCMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TCMD is cheaper than 73.55% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, TCMD is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.29 | ||
| Fwd PE | 27.82 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TCMD is valued a bit cheaper than the industry average as 78.31% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, TCMD is valued cheaply inside the industry as 93.65% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.03 | ||
| EV/EBITDA | 17.39 |
4.3 Compensation for Growth
TCMD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as TCMD's earnings are expected to grow with 30.86% in the coming years.
PEG (NY)N/A
PEG (5Y)6.64
EPS Next 2Y12.18%
EPS Next 3Y30.86%
5. Dividend
5.1 Amount
TCMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
24.86
+0.99 (+4.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners100.61%
Inst Owner Change-0.68%
Ins Owners2.67%
Ins Owner Change5.82%
Market Cap554.13M
Revenue(TTM)292.98M
Net Income(TTM)15.11M
Analysts78.18
Price Target17.17 (-30.93%)
Short Float %8.96%
Short Ratio10.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.49%
Min EPS beat(2)-82.07%
Max EPS beat(2)27.09%
EPS beat(4)3
Avg EPS beat(4)-3.56%
Min EPS beat(4)-82.07%
Max EPS beat(4)27.09%
EPS beat(8)7
Avg EPS beat(8)416.91%
EPS beat(12)10
Avg EPS beat(12)294.05%
EPS beat(16)10
Avg EPS beat(16)151.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-5.08%
Max Revenue beat(2)4.63%
Revenue beat(4)1
Avg Revenue beat(4)-1.98%
Min Revenue beat(4)-5.72%
Max Revenue beat(4)4.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.53%
Revenue beat(12)6
Avg Revenue beat(12)0.56%
Revenue beat(16)9
Avg Revenue beat(16)0.5%
PT rev (1m)24.69%
PT rev (3m)29.49%
EPS NQ rev (1m)-0.57%
EPS NQ rev (3m)-1.14%
EPS NY rev (1m)-0.72%
EPS NY rev (3m)10.75%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-1.49%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)0.64%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.29 | ||
| Fwd PE | 27.82 | ||
| P/S | 1.85 | ||
| P/FCF | 14.03 | ||
| P/OCF | 13.27 | ||
| P/B | 2.84 | ||
| P/tB | 4.51 | ||
| EV/EBITDA | 17.39 |
EPS(TTM)0.77
EY3.1%
EPS(NY)0.89
Fwd EY3.59%
FCF(TTM)1.77
FCFY7.13%
OCF(TTM)1.87
OCFY7.54%
SpS13.41
BVpS8.74
TBVpS5.52
PEG (NY)N/A
PEG (5Y)6.64
Graham Number12.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.54% | ||
| ROE | 7.75% | ||
| ROCE | 8.1% | ||
| ROIC | 5.85% | ||
| ROICexc | 9.95% | ||
| ROICexgc | 21.02% | ||
| OM | 6.3% | ||
| PM (TTM) | 5.06% | ||
| GM | 49.7% | ||
| FCFM | 13.21% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | 0.85 | ||
| Cap/Depr | 33.28% | ||
| Cap/Sales | 0.76% | ||
| Interest Coverage | 10.27 | ||
| Cash Conversion | 162.7% | ||
| Profit Quality | 261.27% | ||
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.36 | ||
| Altman-Z | 6.09 |
F-Score6
WACC8.6%
ROIC/WACC0.68
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
EPS Next Y-11.22%
EPS Next 2Y12.18%
EPS Next 3Y30.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.76%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.33%
Revenue Next Year6.59%
Revenue Next 2Y7.62%
Revenue Next 3Y8.78%
Revenue Next 5YN/A
EBIT growth 1Y-16.93%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year62.97%
EBIT Next 3Y45.27%
EBIT Next 5YN/A
FCF growth 1Y133.94%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y113.95%
OCF growth 3Y149.11%
OCF growth 5Y74.54%
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
Can you provide the ChartMill fundamental rating for TACTILE SYSTEMS TECHNOLOGY I?
ChartMill assigns a fundamental rating of 6 / 10 to TCMD.
What is the valuation status for TCMD stock?
ChartMill assigns a valuation rating of 5 / 10 to TACTILE SYSTEMS TECHNOLOGY I (TCMD). This can be considered as Fairly Valued.
What is the profitability of TCMD stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a profitability rating of 6 / 10.
What are the PE and PB ratios of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The Price/Earnings (PE) ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 32.29 and the Price/Book (PB) ratio is 2.84.
Can you provide the financial health for TCMD stock?
The financial health rating of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 8 / 10.